Skip to content
10-Q

Quarterly Report

Connect Biopharma Holdings Ltd CNTB

0001835268-26-000020

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 62.96M sh
Shares Diluted Q1 2026 · Mar 31, 2026 56.55M sh
Shares Diluted Q1 2026 · Mar 31, 2025 55.35M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $81K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$16.01M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$9.96M
Short Term Investments Q1 2026 · Mar 31, 2026 $0
Short Term Investments Q1 2026 · Dec 31, 2025 $6M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $46.03M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $38.35M
Stockholders Equity Q1 2026 · Mar 31, 2026 $42.62M
Stockholders Equity Q1 2026 · Dec 31, 2025 $41.98M
Stockholders Equity Q1 2026 · Mar 31, 2025 $82.9M
Stockholders Equity Q1 2026 · Dec 31, 2024 $92.17M
Current Liabilities Q1 2026 · Mar 31, 2026 $17.05M
Current Liabilities Q1 2026 · Dec 31, 2025 $13.61M
Total Liabilities Q1 2026 · Mar 31, 2026 $17.44M
Total Liabilities Q1 2026 · Dec 31, 2025 $14.1M
Current Assets Q1 2026 · Mar 31, 2026 $55.02M
Current Assets Q1 2026 · Dec 31, 2025 $50.93M
Total Assets Q1 2026 · Mar 31, 2026 $60.07M
Total Assets Q1 2026 · Dec 31, 2025 $56.08M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.34
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.19
Eps Basic Q1 2026 · Mar 31, 2026 −$0.34
Eps Basic Q1 2026 · Mar 31, 2025 −$0.19
Sga Expense Q1 2026 · Mar 31, 2026 $4.75M
Sga Expense Q1 2026 · Mar 31, 2025 $4.81M
Rd Expense Q1 2026 · Mar 31, 2026 $15.03M
Rd Expense Q1 2026 · Mar 31, 2025 $6.63M
Net Income Q1 2026 · Mar 31, 2026 −$19.4M
Net Income Q1 2026 · Mar 31, 2025 −$10.27M
Operating Income Q1 2026 · Mar 31, 2026 −$19.61M
Operating Income Q1 2026 · Mar 31, 2025 −$11.45M
Revenue Q1 2026 · Mar 31, 2026 $169K
Revenue Q1 2026 · Mar 31, 2025 $0